For CLL cells, there's no place like home
- PMID: 31373247
- PMCID: PMC6928423
- DOI: 10.1080/10428194.2019.1646910
For CLL cells, there's no place like home
Comment on
-
A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemia.Leuk Lymphoma. 2019 Dec;60(14):3461-3469. doi: 10.1080/10428194.2019.1643463. Epub 2019 Jul 27. Leuk Lymphoma. 2019. PMID: 31352850 Clinical Trial.
References
-
- Andritsos L, Byrd JC, Cheverton P, et al. A multicenter phase I study of plerixafor and rituximab in patients with chronic lymphocytic leukemia. Leukemia & Lymphoma 2019. - PubMed
-
- Burkle A, Niedermeier M, Schmitt-Graff A, Wierda WG, Keating MJ, Burger JA. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 2007;110:3316–3325. - PubMed
-
- Burger JA, Burger M, Kipps TJ. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 1999;94:3658–3667. - PubMed
-
- Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006;107:1761–1767. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical